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In Vivo Expression Technology Identifies a Novel
Virulence Factor Critical for Borrelia burgdorferi
Persistence in Mice
Tisha Choudhury Ellis1, Sunny Jain1, Angelika K. Linowski1, Kelli Rike1, Aaron Bestor2, Patricia A. Rosa2,
Micah Halpern1, Stephanie Kurhanewicz1, Mollie W. Jewett1*
1 Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, Florida, United States of America, 2 Laboratory of Zoonotic Pathogens,
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Abstract
Analysis of the transcriptome of Borrelia burgdorferi, the causative agent of Lyme disease, during infection has proven
difficult due to the low spirochete loads in the mammalian tissues. To overcome this challenge, we have developed an In
Vivo Expression Technology (IVET) system for identification of B. burgdorferi genes expressed during an active murine
infection. Spirochetes lacking linear plasmid (lp) 25 are non-infectious yet highly transformable. Mouse infection can be
restored to these spirochetes by expression of the essential lp25-encoded pncA gene alone. Therefore, this IVET-based
approach selects for in vivo-expressed promoters that drive expression of pncA resulting in the recovery of infectious
spirochetes lacking lp25 following a three week infection in mice. Screening of approximately 15,000 clones in mice
identified 289 unique in vivo-expressed DNA fragments from across all 22 replicons of the B. burgdorferi B31 genome. The in
vivo-expressed candidate genes putatively encode proteins in various functional categories including antigenicity,
metabolism, motility, nutrient transport and unknown functions. Candidate gene bbk46 on essential virulence plasmid lp36
was found to be highly induced in vivo and to be RpoS-independent. Immunocompetent mice inoculated with spirochetes
lacking bbk46 seroconverted but no spirochetes were recovered from mouse tissues three weeks post inoculation. However,
the bbk46 gene was not required for B. burgdorferi infection of immunodeficient mice. Therefore, through an initial IVET
screen in B. burgdorferi we have identified a novel in vivo-induced virulence factor critical for the ability of the spirochete to
evade the humoral immune response and persistently infect mice.
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data reported in these studies provide insight into the molecular
mechanisms of gene regulation, they may not fully reflect the
patterns of B. burgdorferi gene expression during an active
mammalian infection. Furthermore, transcriptome analysis of B.
burgdorferi during murine infection has proven difficult given that
spirochete loads in the blood and tissues are too low to recover
sufficient spirochete RNA for direct microarray analysis [11].
In vivo expression technology (IVET) is a gene discovery method
used to identify transcriptionally active portions of a microbial
genome during interaction of the microorganism with a particular
environment or host organism [12,13]. In this system, the
environment itself directly selects for upregulated bacterial loci
[14]. The IVET selection system functions on the premise that
deletion of a biosynthetic gene can lead to attenuation of growth
and persistence of a pathogen in the host environment. This
attenuation can be complemented by expression of the biosynthetic gene driven by promoters that are transcriptionally active in
vivo. Thus, in the environment of interest, in vivo transcriptionally
active promoters can be selected from a genomic library of DNA
fragments cloned upstream of the essential biosynthetic gene [12–

Introduction
Lyme disease is a multi-stage inflammatory disease caused by the
pathogenic spirochete Borrelia burgdorferi, which is transmitted by the
bite of an infected tick [1]. B. burgdorferi has an enzootic life cycle that
requires persistence in two disparate environments, the arthropod
vector and the mammalian host. B. burgdorferi is well adapted to
modulate its expression profile in response to the different
conditions encountered throughout its infectious cycle [2]. Although
the specific environmental signals that induce changes in spirochete
gene expression are not fully defined, it has been reported that
changes in temperature, pH, the presence or absence of mammalian
blood, as well as changes in bacterial growth rate, can affect patterns
of gene expression [2–8]. DNA microarray analysis and proteomics
have been used to examine changes in the global expression profile
of B. burgdorferi grown under in vitro conditions that partially mimic
the tick and mouse environments [3–5]. A rat dialysis membrane
chamber (DMC) implant model, together with microarray technology, has been used to help identify B. burgdorferi genes expressed in
response to mammalian host-specific signals [7–10]. Although the
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wild-type B. burgdorferi varies depending on the environment from
which the spirochetes are derived. For example, the 50%
infectious dose (ID50) of spirochetes derived from partially fed
ticks has been found to be two orders of magnitude lower than that
of log phase in vitro grown B. burgdorferi [19]. In order to
quantitatively assess the impact that adaptation to the mammalian
environment has on B. burgdorferi infectivity the 50% infectious
dose (ID50) of spirochetes derived directly from the mammalian
host was determined and compared to that of log phase in vitro
grown spirochetes. B. burgdorferi are only transiently present in the
blood of immunocompetent mice [20], whereas spirochetes persist
longer in the blood of immunocompromised mice [21]. Therefore,
the blood of severe combined immunodeficiency (scid) mice
infected with B. burgdorferi was used as a source of spirochetes
adapted to the mammalian environment. Strikingly, an inoculum
containing approximately eight in vivo-derived spirochetes was able
to infect five out of six mice, whereas, 5,000 in vitro grown
spirochetes were required to obtain this level of infectivity
(Table 1). The ID50 for in vivo-derived spirochetes was found to
be less than eight organisms. In contrast, the ID50 for in vitro grown
spirochetes was calculated to be 660 organisms. These data
indicate that mammalian host-adapted spirochetes are 100-fold
more infectious than in vitro grown spirochetes, likely due to
appropriate coordinate expression of in vivo-expressed genes
important for murine infectivity.

Author Summary
Lyme disease is caused by tick-bite transmission of the
pathogenic spirochete Borrelia burgdorferi. An increased
understanding of how B. burgdorferi survives throughout
its infectious cycle is critical for the development of
innovative diagnostic and therapeutic protocols to reduce
the incidence of Lyme disease. One of the major difficulties
blocking this effort has been genome-wide identification
of the B. burgdorferi genes that are expressed in the
mammalian host environment. Using in vivo expression
technology (IVET) in B. burgdorferi for the first time, we
have identified B. burgdorferi genes that are expressed
during an active murine infection. We demonstrate that
candidate gene bbk46, encoded on essential linear plasmid
36, is highly expressed in vivo and, unlike some other
known B. burgdorferi in vivo-induced genes, is not RpoS
regulated. Spirochetes lacking bbk46 establish an infection
in mice and elicit an antibody response but are undetectable in mouse tissues three weeks post inoculation. The
bbk46 is not required for spirochete infection of mice
lacking a functional immune system. In sum, development
of an IVET-based approach in B. burgdorferi has identified a
novel virulence gene critical for the spirochete’s ability to
evade the mammalian adaptive immune response.

15]. IVET is a sensitive and versatile method for identification of in
vivo-expressed genes that has been used with pathogenic bacteria
and fungi in a wide variety of host environments and has identified
a number of previously uncharacterized virulence genes [14–18].
Using IVET we have developed and applied a genome-wide
genetic screening approach to identify B. burgdorferi genes that are
expressed during an active murine infection. This is the first time
that an IVET strategy has been applied to B. burgdorferi. Moreover,
we have identified a novel gene on virulence plasmid lp36 that is
strongly induced in vivo and required for B. burgdorferi persistent
infection in the mouse.

The B. burgdorferi IVET system is a robust method for
selection of B. burgdorferi sequences that are expressed
during murine infection
We have developed a genome-wide genetic screening method to
identify B. burgdorferi genes that are expressed during mouse
infection using an in vivo expression technology (IVET) approach
[12,13]. The in vivo expression technology vector, pBbIVET,
carries the B. burgdorferi bmpB Rho-independent transcription
terminator sequence [22] repeated in triplicate (3XTT), to prevent
any read-through promoter activity from the pBSV2* Borrelia
shuttle vector backbone, followed by the promoter-less in vivoessential pncA gene (Figure 1) [23,24]. Spirochetes lacking linear
plasmid (lp) 25 are non-infectious in mice and severely compromised in the tick vector [25–31]. The pncA gene, located on lp25,
encodes a nicotinamidase that is sufficient to restore murine
infectivity to B. burgdorferi lacking the entire lp25 plasmid [24].
Genetic transformation of low-passage, infectious B. burgdorferi
occurs at low frequency and efficiency hampering introduction of

Results
Mammalian host-adapted spirochetes demonstrate a
100-fold decrease in ID50 relative to in vitro grown
spirochetes
It is clear that B. burgdorferi modulates its gene expression profile
at different stages of the infectious cycle [2]. The infectious dose of
Table 1. In vivo-adapted B. burgdorferi are highly infectious.

In vivo grown spirochetes

In vitro grown spirochetes
a

Spirochete dose

Number of mice infected /number
of mice analyzed

Spirochete dose

Number of mice infecteda/number
of mice analyzed

86102

6/6

56104

6/6

1

6/6

56103

6/6

86100

5/6

56102

2/6

56101

1/6

0

5610

0/6

ID50b

660 spirochetes

8610

ID50b

, 8 spirochetes

a

Mouse infection was determined 3 weeks post inoculation by serological response to B. burgdorferi proteins and reisolation of spirochetes from ear, bladder and joint
tissues.
b
The ID50 was calculated according to method of Reed and Muench [83].
doi:10.1371/journal.ppat.1003567.t001
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analyzed by PCR and DNA sequencing and determined to carry
non-identical B. burgdorferi DNA fragments. The strategy used to
construct the pBbIVET library allowed the DNA fragments to be
cloned in either the forward or reverse orientation relative to the
pncA gene. Therefore, a library of 30,000 clones each harboring a
unique 200 bp DNA fragment represented approximately 26
coverage of the 1.5 Mb genome of B. burgdorferi. Although the
initial analysis of the transformation efficiency of B. burgdorferi clone
A3 68-1 demonstrated that each transformation of 20 mg of a
single purified plasmid into this genetic background yielded
approximately 10,000 transformants, this transformation efficiency
was not achieved when 20 mg of complex library plasmid DNA
was transformed into A3 68-1. Forty four transformations of the
library plasmid DNA resulted in recovery of approximately 15,000
individual clones in B. burgdorferi A3 68-1, representing an IVET
library in B. burgdorferi with approximately 16 coverage of the
spirochete genome. As described for the pBbIVET library in E.
coli, a subset of individuals from 15,000 clone library in B.
burgdorferi were analyzed and found to carry non-identical B.
burgdorferi DNA fragments.
Like the BbIVET system described here, many IVET strategies
are based upon complementation of auxotrophy. For microorganisms other than B. burgdorferi these strategies have allowed
negative selection against ‘‘promoter-less’’ clones in minimal
medium in which the auxotroph mutants are unable to grow
[38]. B. burgdorferi lacking pncA are not attenuated for growth in the
complex, undefined B. burgdorferi medium, BSKII. Moreover, there
is currently no minimal medium available that supports the growth
of wild-type B. burgdorferi. Therefore, the BbIVET system did not
include negative selection against ‘‘promoter-less’’ clones in vitro.
179 mice were infected with pools from the B. burgdorferi IVET
library of approximately 100 clones each, with each clone at a dose
of 16104 spirochetes resulting in a total dose of 16106 spirochetes
per mouse. Three weeks post inoculation, mice were sacrificed and
ear, heart, bladder and joint tissues were harvested for reisolation
of infectious spirochetes. 175 out of 179 mice became infected with
B. burgdorferi as determined by reisolation of spirochetes from at
least two or more of the tissue sites analyzed (Table 2). However,
due to the potentially stochastic nature of the kinetics of infection
[39] and/or tissue-specific promoter activity of distinct B.
burgdorferi genomic fragments not all four tissue sites from all 175
infected mice were found to be positive for spirochete reisolation.
Nonetheless, the recovery of live spirochetes from infected mouse
tissues suggested that these spirochetes harbored in vivo active
promoter(s) in the pBbIVET plasmid sufficient to drive expression
of the in vivo-essential pncA gene to restore spirochete mouse
infectivity. Total genomic DNA was isolated from each pool of
reisolated spirochetes from each of the four mouse tissues and the
pBbIVET plasmid DNA rescued in E. coli. Colony PCR using
primers targeting the genomic DNA insert region of the pBbIVET
vector was performed on 24 of the resulting E. coli colonies from
each plasmid rescue transformation. No reisolated spirochetes
were found to harbor a pBbIVET plasmid lacking a genomic
DNA fragment insert. The amplified inserts were analyzed by
restriction digest using a cocktail of the A/T-rich restriction
enzymes to identify those DNA fragments with distinct restriction
patterns, suggesting that these fragments represent different in vivo
active promoters. Up to eleven non-identical restriction digest
patterns were detected for every subset of 24 E. coli transformants
carrying pBbIVET DNA that were analyzed (Figure S1). The
DNA fragments corresponding to each distinct restriction digest
pattern were further analyzed by DNA sequencing and the
identities of the sequences determined by microbial genome
BLAST analysis. Screening of approximately 15,000 BbIVET

a complex DNA library into an infectious background [32,33].
Because B. burgdorferi clones lacking lp25 and lp56 demonstrate
increased transformability [34], we isolated a clonal derivative of
the low-passage infectious clone A3 that lacks both lp25 and lp56.
This clone was designated A3 68-1 [35]. Clones A3 and A3 68-1
were transformed by electroporation with 20 mg of a Borrelia
shuttle vector. The transformation frequency and efficiency of A3
68-1 was determined relative to that of the A3 parent. As expected,
genetic transformation of A3 68-1 occurred at a high frequency
and efficiency. We recovered approximately 2,000 transformants/
ml in clone A3 68-1, whereas no transformants were recovered
with a parallel transformation of clone A3 (data not shown). In
order to test the function of the B. burgdorferi IVET system, the
promoter for the in vivo essential ospC gene [36], was cloned in front
of the promoter-less pncA gene in pBbIVET (Figure 1), creating
plasmid pBbIVET-ospCp. This plasmid, along with pBbIVET
alone, was transformed into the non-infectious, low-passage,
highly transformable B. burgdorferi clone A3 68-1. All clones were
tested for their abilities to infect groups of 6 C3H/HeN mice at an
infectious dose 100 (ID100) of 16104 spirochetes [37], indicating
the presence or absence of an active promoter sufficient to drive
expression of pncA thereby restoring infectivity. Spirochetes were
reisolated from the ear, bladder and joint tissues of 5/6 mice
infected with B. burgdorferi harboring pBbIVET-ospCp. No
spirochetes were reisolated from mice (0/6) infected with B.
burgdorferi carrying the promoter-less pBbIVET alone. Together
these data demonstrated that our promoter trap system functioned
with a known in vivo active promoter.

Screening for B. burgdorferi genes expressed during
murine infection
A B. burgdorferi genomic DNA library using an average DNA
fragment size of approximately 200 bps was constructed upstream
of the promoter-less pncA gene (Figure 1) in the pBbIVET vector in
E. coli, yielding approximately 30,000 independent clones. A small
subset of individuals from the 30,000 clone library in E. coli was

Figure 1. Schematic representation of the pBbIVET vector.
Features of this vector include: 3XTT, the transcriptional terminator
sequence for bmpB [22] repeated in triplicate; pncA, promoterless pncA
gene; flgBpkan, kanamycin resistance cassette; zeo, zeocin resistance
marker; ColE1, E. coli origin of replication; ORFs 1, 2, 3, B. burgdorferi cp9
replication machinery. The EcoRI restriction site was used to clone the B.
burgdorferi control in vivo-expressed promoter, ospCp, as well as the B.
burgdorferi (Bb) gDNA library, in front of the promoterless pncA gene.
The pBbIVET vector was derived from the B. burgdorferi shuttle vector
pBSV2* [80].
doi:10.1371/journal.ppat.1003567.g001
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Table 2. The B. burgdorferi IVET system selects for in vivo-active promoters.

Number of BbIVET
clones screened

,15,000

Positive reisolation of infectious spirochetes from mouse tissues

Number of unique
genomic fragments
recovered

a

Ear

Heart

Bladder

Joint

175/179

173/179

172/179

174/179

289

a
Number of mice positive for spirochete reisolation/number of mice analyzed. Four mice were reisolate-negative for all tissues analyzed. Three mice were reisolatenegative for the bladder tissue. One mouse was reisolate-negative for the heart and joint tissues. One mouse was reisolate-negative for the heart tissue.
doi:10.1371/journal.ppat.1003567.t002

phenotype have not been fully defined [37]. IVET identified a
candidate in vivo-expressed promoter sequence, Bbive162, which
mapped to lp36. This sequence was found to be 60 bp long, with
48 bp immediately upstream of and in the same direction as the
BBK46 open reading frame (Figure 2), suggesting that the bbk46
gene may be expressed during mammalian infection and may
contribute to the essential role of lp36 in B. burgdorferi infectivity.
Therefore, the bbk46 gene was selected for further analysis.

clones through mice resulted in the identification of 289 nonidentical B. burgdorferi in vivo-expressed (Bbive) DNA fragments from
across the chromosome and all 21 plasmid replicons of the B.
burgdorferi B31 segmented genome (Table 2). Although the 1:1
molar ratio of insert to vector used to generate the pBbIVET
library did not preclude insertion of more than one fragment into
each clone, only 20 out of the 289 clones were found to harbor two
distinct DNA fragments. Of these clones the 39 DNA fragment,
proximal to the pncA ORF, was assumed to be the active promoter
and was included in the subsequent analyses.

Expression of the bbk46 gene is induced during murine
infection

B. burgdorferi in vivo expressed promoters map to
distinct classes of putative regulatory sequences across
the genome

Our BbIVET screen identified gene bbk46 as a putative in vivoexpressed gene. The BbIVET screen was designed to identify B.
burgdorferi DNA fragments that are expressed in vivo and did not
discriminate between those promoters that are specifically induced
in vivo and those promoters that are expressed both in vitro and in
vivo. Therefore, quantitative reverse transcription PCR (qRTPCR) was used to validate the expression of bbk46 in vivo and to
determine whether bbk46 expression was upregulated in vivo
compared to in vitro. Total RNA was isolated from bladder tissue
collected from mice infected with 16105 wild-type B. burgdorferi
three weeks post-inoculation as well as log phase in vitro grown
spirochetes. RNA was converted to cDNA using random hexamer
primers and the mRNA level of each target gene was measured
relative to the constitutive recA gene using quantitative PCR. The
gene expression levels of flaB and ospC were also measured as
control constitutively-expressed and in vivo-induced genes, respectively. These data demonstrated that although bbk46 was expressed
during in vitro growth, expression of this gene was increased more
than 100-fold during mammalian infection (Figure 3A). Consistent
with their known patterns of gene regulation, flaB expression was
relatively unchanged in vivo compared to in vitro; whereas, ospC
demonstrated a nearly 1000-fold increase in expression in vivo
compared to in vitro (Figure 3A). Moreover, the relative amount of
bbk46 expression during in vitro growth was found to be
approximately 10-fold more than that of ospC. Whereas, the in
vivo expression levels of genes bbk46, ospC and flaB were similar.
RpoS is a global regulator that controls expression of genes
expressed during mammalian infection, including ospC [2].
Because bbk46 expression was induced in vivo in a manner similar
to that of ospC, we sought to determine whether, like ospC, bbk46 is
an RpoS-regulated gene. RNA was isolated from stationary phase
temperature-shifted wild-type and DrpoS mutant spirochetes, a
growth condition previously shown to induce expression of rpoS
and rpoS-regulated genes [42]. Quantitative RT-PCR was then
performed for genes bbk46, flaB, ospC and recA, as described above.
As expected, ospC expression was increased approximately 20
times in the presence compared to the absence of rpoS (Figure 3B).
In contrast, bbk46 expression was RpoS-independent under these
growth conditions (Figure 3B). Likewise, no RpoS-dependent
change in gene expression was detected for flaB. Interestingly, the

Genomic mapping of the 289 unique Bbive promoters identified
in this genetic screen demonstrated that 67% of the sequences
mapped to sense DNA in the same direction as annotated open
reading frames, 27% mapped to antisense DNA in the opposite
direction to annotated open reading frames and 6% mapped to
intergenic regions lacking annotated open reading frames. Of the
large percentage of sense sequences, 41%, which represented
28% of the total Bbive sequences, mapped to regions just
upstream of and in the same orientation to annotated open
reading frames, suggesting that these sequences are promoters for
the associated open reading frames and that these open reading
frames are candidate in vivo-expressed genes. The remaining 59%
of the sense sequences, which represented 39% of the total Bbive
sequences, mapped within annotated open reading frames,
suggesting the possibility for promoter elements within B.
burgdorferi genes. Similar findings of putative transcriptional start
sites within genes and operons have been reported for other
bacterial pathogens [40,41]. The sequences that mapped to
putative promoter locations in the genome and the genes
associated with these promoters were prioritized for further
analysis. Among the list of 80 sequences, 9 promoter regions were
represented by two overlapping genomic DNA fragments. Five of
these overlapping sequence pairs shared the same 39 end,
suggesting that the sequences belonging to each pair contained
the same promoter. Whereas, the other four overlapping
sequence pairs harbored distinct 39 ends, suggesting that each
sequence contained a unique promoter. The 71 in vivo-expressed
candidate genes have been annotated to encode proteins in
various functional categories including: cell division, cell envelope, replication, metabolism, motility, protein synthesis, transport and unknown functions (Table 3).

IVET identified candidate gene bbk46 on virulence
plasmid lp36
Linear plasmid 36 is required for B. burgdorferi mouse infection;
however, the genetic elements on lp36 that contribute to this
PLOS Pathogens | www.plospathogens.org

4

August 2013 | Volume 9 | Issue 8 | e1003567

IVET in B. burgdorferi

Table 3. B. burgdorferi in vivo-expressed candidate genes organized by functional category.
Bbive clonea

Replicon

ORFb

Protein designation, Annotated functionc

chromosome

BB0715

FtsA cell division protein

15

chromosome

BB0213

Putative lipoprotein

94

chromosome

BB0760

Gp37 protein

175

lp54

BBA36

Lipoprotein

271

lp54

BBA57

Lipoprotein

297

lp25

BBE16

BptA

151

lp28-2

BBG01

Putative lipoprotein

267

lp38

BBJ34

Putative lipoprotein

269

lp38

BBJ51

VlsE paralog, pseudogene

162

lp36

BBK46

Immunogenic protein P37, authentic frameshift

77

cp32-8, cp32-3, cp32-7, cp32-9,
lp56, cp32-4, cp32-6, cp32-1

BBL28, BBS30, BBO28, BBN28, BBQ35,
BBR28, BBM28, BBP28

Mlp lipoprotein family

274

chromosome

BB0111

DnaB replicative helicase

226

chromosome

BB0632

RecD exodeoxyribonuclease V, alpha chain

152

lp28-3

BBH13

RepU replication machinery

62

chromosome

BB0057

Gap glyceraldehyde-3-phosphate dehydrogenase, type
1

34

chromosome

BB0327

Glycerol-3-phosphate O acyltransferase

44

chromosome

BB0368

NAD(P)H-dependent glycerol-3-phosphate
dehydrogenase

47

chromosome

BB0381

Trehalase

81

chromosome

BB0676

Phosphoglycolate phosphate

chromosome

BB0704

AcpP acyl carrier protein

14

chromosome

BB0181

FlbF putative flagellar protein

29

chromosome

BB0293

FlgB flagellar basal body rod

290

chromosome

BB0755

Flagellar hook-basal body complex protein

65

chromosome

BB0551

CheY-1 chemotaxis response regulator

222

chromosome

BB0568

Chemotaxis response regulator protein-glutamate
methylesterase

cp32-8, cp32-7, cp32-1, cp32-3,
cp32-6, cp32-4

BBL23, BBO23, BBP23, BBS23, BBM23,
BBR23

Holin BlyA family

chromosome

BB0031

LepB signal peptidase I

chromosome

BB0113

RpsR ribosomal protein S18

Cell division
289
Cell envelope

DNA replication

Energy metabolism

Fatty acid and phospholipid
metabolism
85
Motility and chemotaxis

Prophage function
295
Protein fate
193
Protein synthesis
202
216, 217

chromosome

BB0485

RplP ribosomal protein L16

58

chromosome

BB0495

RpsE 30S ribosomal protein S5

59

chromosome

BB0496

50S ribosomal protein L30

219

chromosome

BB0503

RplQ ribosomal protein L17

232

chromosome

BB0660

GTP-binding Era protein

288

chromosome

BB0682

TrmU tRNA (5-methylaminomethyl-2-thiouridylate)methyltransferase

208

chromosome

BB0379

Protein kinase C1 inhibitor

50

chromosome

BB0420

Hk1 histidine kinase

Regulation
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Table 3. Cont.
Bbive clonea

Replicon

ORFb

Protein designation, Annotated functionc

lp25

BBE07

Pfs protein, pseudogene

1

chromosome

BB0389

RpoB DNA-directed RNA polymerase, beta subunit

287

Chromosome

BB0607

PcrA ATP-dependent DNA helicase

84

chromosome

BB0697

RimM 16S rRNA processing protein

204

chromosome

BB0318

MglA methylgalactoside ABC transporter ATP-binding
protein

46

chromosome

BB0380

MgtE Mg2+ transport protein

56

chromosome

BB0049

Hypothetical protein

69

chromosome

BB0063

Pasta domain protein

2

chromosome

BB0102

Conserved hypothetical

Nucleoside salvage
148
Transcription

Transport

Unknown

8

chromosome

BB0138

Conserved hypothetical

13

chromosome

BB0176

ATPase family associated with various cellular activities

23

chromosome

BB0265

Conserved hypothetical

212

chromosome

BB0428

Conserved hypothetical

52, 53

chromosome

BB0429

Conserved hypothetical

220

chromosome

BB0504

Conserved hypothetical

67

chromosome

BB0562

Conserved hypothetical

223

chromosome

BB0577

Conserved hypothetical

71

chromosome

BB0592

Caax amino protease family

73

chromosome

BB0619

DHH family phosphoesterase function

96

chromosome

BB0799

Conserved hypothetical

240

cp26

BBB27

Unknown essential protein

145, 146

lp25

BBE0036

Hypothetical protein

147

lp25

BBE01

Conserved hypothetical

265, 266

lp38

BBJ30

Conserved hypothetical

171

lp38

BBJ36

Conserved hypothetical

173

lp38

BBJ46

Conserved hypothetical

129, 296

cp32-8, cp32-1, cp32-7, lp56,
cp32-9

BBL41, BBP40, BBO42, BBQ48, BBN41

Conserved hypothetical

130, 151

cp32-8, cp32-1, cp32-6

BBL42, BBP41, BBM41

Conserved hypothetical

117

cp32-6, lp56, cp32-9, cp32-8,
cp32-3, cp32-1, cp32-4

BBM18, BBQ25, BBN18, BBL18,
BBS18,BBP18, BBR18

Conserved hypothetical

182, 183

lp56

BBQ41

PF-49 protein

188

lp56

BBQ84.1

Conserved hypothetical

189

lp56, lp28-3, lp17

BBQ89, BBH01, BBD01

Conserved domain protein

244

cp32-4, cp32-3, cp32-6, lp56,
cp32-8, cp32-9

BBR05, BBN05, BBM05, BBQ12, BBL05,
BBO05, BBP05

Lyme disease protein of unknown function

157

lp28-4

BBI07

Conserved hypothetical

a

In some cases two Bbive clones shared overlapping, non-identical sequence, as indicated by two Bbive clone numbers.
ORF, open reading frame that maps just downstream and in the same orientation to the Bbive sequence.
Annotation described by Fraser et al. [45].
doi:10.1371/journal.ppat.1003567.t003
b
c

amount of flaB expression detected in the stationary phase
temperature-shifted spirochetes (Figure 3B) was dramatically
decreased compared to the amount of flaB expression detected
in log phase and in vivo grown spirochetes (Figure 3A), suggesting

PLOS Pathogens | www.plospathogens.org

that flaB is not expressed at the same level under all growth
conditions. Together these data demonstrated that bbk46 was
highly induced during murine infection and bbk46 expression was
not controlled by RpoS during in vitro growth.
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Figure 2. The nucleotide and putative amino acid sequence of the BBK46 open reading frame. The reverse complement of nucleotides
28391 to 29474 on lp36, encompassing bbk46 (Genbank GeneID: 1194234) and its putative promoter sequence. The nucleotide sequence of Bbive162
is underlined. The putative ribosome binding site is shown in bold italics. The putative BBK46 amino acid sequence is shown in bold. The stop codons
at nucleotides 625 and 820 are highlighted in gray. The position of the inserted FLAG-epitope tag sequence is indicted with a star (*). The position of
the inserted cMyc-epitope tag sequence is indicated with a number sign (#).
doi:10.1371/journal.ppat.1003567.g002

members of paralogous gene family 75 are conserved within B.
burgdorferi isolates but are not present in the relapsing fever
spirochetes. The B. burgdorferi clone B31 BBK45, BBK48 and
BBK50 proteins are predicted to be 301, 288 and 332 amino acids,
respectively. However, B. burgdorferi clone B31 bbk46 is annotated
as a pseudogene as a result of an authentic frame shift resulting in
a TAA stop codon at nucleotide 625 [43–45], thereby producing a
putative 209 amino acid protein. In contrast, the BBK46 homolog

The bbk46 open reading frame fails to produce
detectable amounts of protein during in vitro growth
The bbk46 gene is a member of paralogous gene family 75,
which also includes lp36-encoded genes bbk45, bbk48 and bbk50, all
of which are annotated to encode putative P37 immunogenic
lipoproteins [43–45] (Figure 4). These genes are located on the
right arm of lp36 in B. burgdorferi clone B31, which is a highly
variable region among distinct B. burgdorferi isolates [44]. The
PLOS Pathogens | www.plospathogens.org
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BBK46 protein production was assessed in both E. coli and B.
burgdorferi. Immunoblot analyses using aFLAG and acMyc
monoclonal antibodies resulted in detection of a FLAG-epitope
tagged protein of an approximate molecular mass of 23 kDa,
which is the predicted size of the 209 amino acid BBK46 protein,
in the E. coli clones carrying both the flaBp-driven and the bbk46pdriven constructs (Figure 6). Surprisingly, no FLAG epitope tagged
protein was detected in either B. burgdorferi clone (Figure 6),
although bbk46 gene expression was observed in these clones (data
not shown), indicating that the lack of detectable BBK46 protein
was not likely the result of a transcription defect. Furthermore, no
cMyc epitope tagged protein was detected in either E. coli or B.
burgdorferi. Together these data suggested that although the bbk46
ORF is competent to produce a 23 kDa protein in E. coli and the
transcript is expressed in B. burgdorferi during in vitro growth, the
protein is either not produced or is rapidly turned over in log
phase in vitro grown B. burgdorferi.
As a putative member of the P37 immunogenic lipoprotein
family, BBK46 is predicted to localize to the spirochete outer
surface and to be immunogenic during mammalian infection.
Therefore, recombinant BBK46, lacking the first 32 amino acids
that are predicted to comprise the signal sequence for the
lipoprotein, was produced in E. coli as an N-terminal fusion to
glutathione S-transferase (GST). To assess the immunogenicity of
the BBK46 protein, immunoblot analysis was performed using
purified rGST-BBK46 probed with mouse immune serum
collected 21 days post inoculation with 16104 wild-type B.
burgdorferi. The rGST-BBK46 protein was found to be nonimmunoreactive with mouse immune serum, in contrast to the
control antigen BmpA (Figure S2). These data suggest that, if
produced in B. burgdorferi, BBK46 is not an immunoreactive
antigen. However, these data do not rule out the possibility that
the immunogenic epitope is not present or available in the
recombinant protein produced in E. coli.

Figure 3. Expression of the bbk46 gene is upregulated during
murine infection and is RpoS-independent. Total RNA was
isolated from bladder tissue collected from (A) mice infected with
16105 wild-type B. burgdorferi three weeks post-inoculation (in vivo,
gray bars) and from log phase in vitro grown spirochetes (in vitro, white
bars) or (B) stationary phase temperature-shifted stationary phase in
vitro grown wild-type (white bars) or DrpoS (gray bars) B. burgdorferi.
RNA was reverse transcribed to cDNA using random hexamer primers.
The expression of bbk46, flaB and ospC were quantified using
quantitative reverse transcription polymerase chain reaction (qRT-PCR)
and a standard curve analysis method. The mRNA levels of the bbk46,
flaB and ospC gene transcripts were normalized to that of the
constitutive recA gene. The data are expressed as the gene transcript/
recA transcript. The data represent the average of triplicate qRT-PCR
analyses of 3 biological replicates. Error bars represent the standard
deviation from the mean.
doi:10.1371/journal.ppat.1003567.g003

The bbk46 gene is required for B. burgdorferi persistence
in immunocompetent mice
In vitro growth analysis demonstrated that the bbk46 mutant and
complemented clones had no detectable in vitro phenotypes
(Figure 5C). Therefore, to examine the role of bbk46 in mouse
infectivity, groups of five C3H/HeN female mice were needle
inoculated intradermally under the skin of the upper back with
16104 wild-type, Dbbk46/vector or Dbbk46/bbk46+ spirochetes.
Three weeks post inoculation, mice were assessed for B. burgdorferi
infection by serology and reisolation of spirochetes from the
inoculation site, ear, bladder and joint tissues. All five mice from
each infection group were seropositive for anti-B. burgdorferi
antibodies (Figure 7, Table 4). Surprisingly however, no
spirochetes were reisolated from all tissues examined from the
five mice inoculated with the Dbbk46/vector clone (Table 4),
whereas, all five mice inoculated with the wild-type or the Dbbk46/
bbk46+ clone resulted in reisolation of spirochetes from all tissues
analyzed (Table 4). Together these data demonstrated that
spirochetes lacking the bbk46 gene transiently infected and elicited
a humoral response in mice, but were unable to maintain a
persistent infection in mouse tissues. To further define the
contribution of the host immune response to the inability of
spirochetes lacking the bbk46 genes to cause a persistent infection,
groups of five severe combined immunodeficiency (scid) mice were
inoculated with 16104 wild-type, Dbbk46/vector or Dbbk46/
bbk46+ spirochetes. Three weeks post inoculation the animals were
assessed for infection by reisolation of spirochetes from the ear,
bladder and joint tissues. Consistent with the hypothesized role of

in clone N40, BD04, harbors a CAA codon at nucleotide 625,
resulting in a glutamic acid residue at amino acid 209 and
producing a putative 273 amino acid protein [46]. Sequence
analysis of the cloned bbk46 open reading frame confirmed the
presence of the TAA stop codon at nucleotide 625 (Figure 2). To
experimentally determine the size of the BBK46 protein produced
in B. burgdorferi B31 the bbk46 ORF along with a FLAG epitope tag
sequence prior to the stop codon at nucleotide 625 and a cMyc
epitope tag sequence prior to the stop codon at nucleotide 820
(Figure 2) was cloned into the B. burgdorferi shuttle vector pBSV2G
under the control of either the constitutive flaB promoter or the
putative endogenous bbk46 promoter. A mutant clone lacking the
entire BBK46 open reading frame was constructed by allelic
exchange and verified by PCR analysis (Figure 5A and 5B). The
bbk46 mutant clone was transformed with the shuttle vectors
carrying the epitope tagged bbk46 constructs. All transformants
were verified to contain the plasmid content of the parent clone.
PLOS Pathogens | www.plospathogens.org
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Figure 4. Amino acid alignment of the putative members of the immunogenic protein P37 family encoded on lp36. Shown is an
amino acid alignment of the P37 protein family members BBK45 (GenBank accession no. NP_045617.2), BBK46 (translated bbk46, Genbank GeneID:
1194234), BBK48 (GenBank accession no. NP_045619.1) and BBK50 (GenBank accession no. NP_045621.1). Amino acids identical to the consensus
sequence are shaded. The predicted SpLip lipobox sequence [81] is indicted with five stars. Dashes represent spaces introduced for optimal sequence
alignment. The positions of the two stop codons in the bbk46 translation are indicated with arrows. Amino acid sequences were aligned using the
CLUSTAL W algorithm in the MEGALIGN program from the DNASTAR Lasergene suite.
doi:10.1371/journal.ppat.1003567.g004

during mammalian infection. Historically, genetic manipulation of
low passage, infectious B. burgdorferi has been challenged by the low
transformation frequencies of these spirochetes, preventing application of classic in vivo genetic screening techniques such as in vivo
expression technology (IVET) and signature-tagged mutagenesis
(STM) [47] to identify B. burgdorferi genetic elements important for
pathogenicity. However, advances in the understanding of the B.
burgdorferi restriction modification systems that inhibit transformation [34,48–51] have recently allowed construction and characterization of a comprehensive STM mutant library in infectious B.
burgdorferi [52]. The foundation for our strategy for development of
IVET in B. burgdorferi was based upon the spirochete’s requirement
of lp25 for both restriction modification and virulence functions.
Spirochetes lacking lp25 are highly transformable but non-

bbk46 in immune evasion and persistence, four out of five
immunodeficient mice inoculated with the Dbbk46 mutant were
positive for spirochete reisolation from all tissues examined
(Table 4). These data demonstrated that a functional host immune
response is required for the clearance of spirochetes lacking bbk46
from mouse tissues 3 weeks post infection, indicating that bbk46 is
essential for the ability of B. burgdorferi to avoid killing by the host
immune system in order to establish a persistent infection.

Discussion
In this study we have successfully adapted and applied for the
first time an IVET-based genetic screen for use in B. burgdorferi for
the purpose of identifying spirochete genes that are expressed
PLOS Pathogens | www.plospathogens.org
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Figure 6. BBK46 protein production is detectable in E. coli but
not in B. burgdorferi. Immunoblot analysis of total protein lysate
prepared from 1.56108 B. burgdorferi Dbbk46 (Bb) or E. coli harboring
either pBSV2G flaBp-bbk46-FLAG-cMyc (flaBp) or pBSV2G bbk46p-bbk46FLAG-cMyc (bbk46p). Protein lysates were separated by SDS-PAGE and
immunoblots performed using anti-FLAG monoclonal antibodies (a
FLAG) and anti-cMyc monoclonal antibodies (a cMyc). 300 ng of
purified PncA-FLAG [23] and GST-BmpA-cMyc [77] proteins served as
positive controls (+) for each antibody. The positions of markers to the
left of the panel depict protein standard molecular masses in
kilodaltons.
doi:10.1371/journal.ppat.1003567.g006

Figure 5. Generation of the Dbbk46 mutant and genetic
complemented clones in B. burgdorferi. (A) Schematic representation of the wild-type (WT) and Dbbk46 loci on lp36. The sequence of the
entire bbk46 open reading frame was replaced with a flaBp-aadA
antibiotic resistance cassette [37,82]. Locations of primers for analysis of
the mutant clones are indicated with small arrows and labels P7–P12,
P19 and P20. Primer sequences are listed in Table 5. (B) PCR analysis of
the Dbbk46 mutant clone. Genomic DNA isolated from WT and Dbbk46/
vector spirochetes served as the template DNA for PCR analyses. DNA
templates are indicated across the bottom of the gel image. The primer
pairs used to amplify specific DNA sequences are indicated at the top of
the gel image and correspond to target sequences as shown in A.
Migration of the DNA ladder in base pairs is shown to the left of each
image. (C) In vitro growth analysis of mutant clones. A3-68DBBE02 (WT),
bbk46::flaBp-aadA/pBSV2G (Dbbk46/vector) and bbk46::flaBp-aadA/
pBSV2G-bbk46 (Dbbk46/bbk46+) spirochetes were inoculated in triplicate at a density of 16105 spirochetes/ml in 5 ml of BSKII medium.
Spirochete densities were determined every 24 hours under dark field
microscopy using a Petroff-Hausser chamber over the course of
96 hours. The data are represented as the number of spirochetes per
ml over time (hours) and is expressed as the average of 3 biological
replicates. Error bars indicate the standard deviation from the mean.
doi:10.1371/journal.ppat.1003567.g005

Figure 7. Spirochetes lacking bbk46 retain seroreactivity in
mice. Immunoblot analysis of sera collected three weeks post
inoculation from groups of five C3H/HeN mice inoculated with clone
A3-68DBBE02 (WT), bbk46::flaBp-aadA/pBSV2G (Dbbk46/vector) and
bbk46::flaBp-aadA/pBSV2G-bbk46 (Dbbk46/bbk46+) at a dose of 16104
spirochetes per mouse. (A) Total protein lysate from B. burgdorferi clone
B31 A3 was probed with the serum from each individual mouse (1–5).
(B) Purified recombinant GST-OspC protein was probed with pooled
sera from the five mice in each infection group or aOspC polyclonal
antibodies. The positions of markers to the left of the panel depict
protein standard molecular masses in kilodaltons.
doi:10.1371/journal.ppat.1003567.g007

infectious in mice [27–29,34]. Restoration of the lp25-encoded
pncA gene to lp252 spirochetes restores wild-type infectivity [24]
but maintains high transformation frequency. At the time of the
development of the pBbIVET system the true start codon of the
pncA gene was not defined; therefore, the promoter-less pncA gene
construct in the pBbIVET plasmid used an engineered AUG start
codon and was missing the first 24 nucleotides of the now defined
pncA ORF [23]. Furthermore, this construct was purposefully
PLOS Pathogens | www.plospathogens.org
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Table 4. The bbk46 gene is required for persistent infection of immunocompetent mice.

Clone

Serologya

Positive reisolation of spirochetes from mouse tissuesb
Inoculation site

Ear

Bladder

Joint

Immunocompetent mice
wild-type

5/5

5/5

5/5

5/5

5/5

Dbbk46/vector

5/5

0/5

0/5

0/5

0/5

Dbbk46/bbk46+

5/5

5/5

5/5

5/5

5/5

wild-type

NA

NA

5/5

5/5

5/5

Dbbk46/vector

NA

NA

4/5

4/5

4/5

Dbbk46/bbk46+

NA

NA

5/5

5/5

5/5

Immunodeficient mice

a

Determined 3 weeks post inoculation by serological response to B. burgdorferi total protein lysate and recombinant OspC protein. NA, not applicable.
Number of mice positive for spirochete reisolation/number of mice analyzed. NA, not applicable.
doi:10.1371/journal.ppat.1003567.t004
b

designed without a ribosome binding site (RBS) and was
dependent upon the cloned B. burgdorferi DNA fragments to
contain both a promoter and a functional RBS. Although we
acknowledge that this requirement may have limited the number
of clones identified in our screen, during development of the
BbIVET system we found that inclusion of an RBS sequence in
the promoterless pncA construct resulted in vector-driven PncA
production in the absence of a promoter. Thus, in order to reduce
the possibility of recovering false positive clones, the pBbIVET
system was designed without an RBS. The enzyme Tsp509I was
selected to generate the DNA fragments for the pBbIVET library
because the AATT restriction site of this enzyme is present
approximately every 58 bp in the B. burgdorferi B31 genome.
However, it is possible that DNA fragments generated with this
enzyme will not result in sequences that contain a 39 RBS
appropriately distanced from the start codon of the pncA ORF,
thereby limiting the number of clones identified in the screen.
Screening of a 15,000 clone B. burgdorferi genomic library in
mice identified 289 DNA sequences from across all 22 B. burgdorferi
replicons capable of promoting pncA expression resulting in an
infectious phenotype. It is likely that the BbIVET screen did not
achieve saturation because the number of clones analyzed was
only estimated to cover the B. burgdorferi genome one time, under
the assumption that each cloned DNA fragment in the library was
unique. Analysis of the pBbIVET library in B. burgdorferi suggested
that the library was composed of 15,000 unique clones. However,
because only a small fraction of the library was examined for the
sequences of the DNA fragment inserts, our findings do not rule
out the potential that the library was composed of less than 15,000
non-identical clones and therefore, may represent less than 16
coverage of the genome. Of the 175 mice infected with the
pBbIVET library, 10% resulted in reisolation of a single clone,
62% resulted in reisolation of two to five unique clones, and 28%
resulted in reisolation of six to eleven unique clones. Furthermore,
57% of the 289 Bbive sequences were only recovered once;
whereas, 39% of the sequences were recovered two to five times
and 4% of the sequences were recovered six to twelve times. These
data are indicative of the amount of redundancy in the screen and
suggest that although the screen may not have been representative
of the entire B. burgdorferi genome, a large percentage of mice
became infected with multiple clones and many of the Bbive
sequences were recovered more than once.
We found that 71 of the Bbive sequences mapped to canonical
promoter positions upstream of annotated open reading frames in
PLOS Pathogens | www.plospathogens.org

the B. burgdorferi genome. Unexpectedly, the well characterized in
vivo-expressed ospC promoter was not among these sequences.
However, the ospCp was successfully recovered in our functional
validation of the BbIVET system, suggesting that the BbIVET
screen had not reached complete saturation of the genome and
with further screening of the BbIVET library the ospCp sequence
may be recovered. Alternatively, given that ospC expression is
known to be down-regulated after the initial stages of infection
[11,53–56] it is possible that in the context of a mixed infection
individual pBbIVET clones carrying the ospCp lack a fitness
advantage due to decreased expression three weeks post inoculation and may not be recovered in our screen. This explanation
may appear to conflict with the findings reported herein that ospC
expression is high at three weeks post inoculation and the ospCp
served as a robust positive control promoter for the BbIVET
system. However, down-regulation of ospC expression at this time
point in infection is a stochastic process that occurs at the level of
the individual spirochete and does not occur simultaneously across
the entire population [55]. Although at the population level the
ospCp is expressed at this time point in our studies, in the context of
the BbIVET screen individual clones carrying the ospCp may
express reduced amount of pncA and may be out competed by
other BbIVET clones carrying stronger promoters.
A subset of the genes identified in the BbIVET screen included
known in vivo-expressed genes, which provided validation that our
genetic system was working as expected and was sufficiently
powerful. The screen recovered the promoter for genes bba36
(Bbive175), bba57 (Bbive271), bbb27 (Bbive240), bbj34 (Bbive267),
bbj36 (Bbive171), bbj51 (Bbive269), bb0213 (Bbive15) and bb0760
(Bbive94), all of which have been shown previously to be expressed
during mammalian infection [11]. Furthermore, bba57 was
recently reported to be up-regulated in vivo and to contribute to
pathogenesis in the mouse [57]. The bptA gene encodes a function
that has been shown to be required for B. burgdorferi survival in the
tick and to contribute to mouse infectivity [30,31]. In addition,
Bbive14, 58, 232, 84, 269, 295 and 77 are associated with genes
that have been shown to be up-regulated in in vivo-like conditions
and/or gene products that are immunogenic in humans and mice
[5,8,58,59]. Notably, few in vivo-expressed candidate genes
identified using BbIVET were previously observed to be upregulated in mammalian host-adapted spirochetes derived from
growth within rat dialysis membrane chambers (DMCs). Genes
identified in our analyses that have also been detected by
microarray analysis of DMC grown spirochetes include bba36
11
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might not be discovered using other genome-wide gene expression
methods. Surprisingly, BBK46 protein was not detected in
spirochetes expressing FLAG epitope tagged bbk46 under the
control of the putative native promoter or the constitutive flaB
promoter. Moreover, sera from B. burgdorferi infected mice were
non-immunoreactive against recombinant BBK46 protein. In
support of these data, no peptide corresponding to BBK46 has
been detected in genome-wide proteome analysis of B. burgdorferi
under different environmental conditions [63]. Our findings
suggest that despite high gene expression, the encoded BBK46
protein is produced at low levels in the spirochete and/or BBK46
is rapidly turned over in the cell. Alternatively, bbk46 may function
as an RNA. The molecular nature of the functional product of
bbk46 is currently under investigation.
Deletion of bbk46 from low-passage, infectious B. burgdorferi
resulted in no observable in vitro growth defect. Immunocompetent
mice needle inoculated with spirochetes lacking bbk46 were found
to be seropositive for B. burgdorferi antibodies three weeks postinfection, although the serological responses appeared to be
slightly diminished relative to those of mice infected with the wildtype and complemented clones. Surprisingly, however, no live
spirochetes were reisolated from all tissues examined from the
mutant infected mice at this same time point. Conversely, all mice
infected with the wild-type or complemented clone were both
seropositive and reisolation positive. Furthermore, bbk46 was not
required for spirochete survival in immunocompromised mice.
These data indicate that bbk46 is dispensable for the initial stages
of B. burgdorferi murine infection but this gene is essential for B.
burgdorferi persistence in mouse tissues and may contribute to a
mechanism of spirochete evasion of host-acquired immune
defenses.
B. burgdorferi survival in the mammalian host requires diverse
mechanisms that allow the spirochete to resist and evade the
host’s immune responses. However, the genetic components of
these important properties of the pathogen have yet to be well
defined. Here we demonstrate that spirochetes lacking bbk46
establish an initial infection and are seroreactive but are unable to
persist in murine tissues following host antibody production. To
our knowledge a similar phenotype has been documented for
only two other B. burgdorferi genes, the lp28-1 encoded vls
antigenic variation locus [27,29,64–66] and the chromosomally
encoded lmp-1(bb0210) gene [67]. Moreover, analogous to the
bbk46 mutant, the phenotypes of spirochetes lacking a functional
vls locus as well as spirochetes lacking lmp-1 have been shown to
be dependent on the host immune response as these mutants
demonstrate wild-type survival under immune privileged growth
conditions and in immunocompromised mice [27,29,65–67].
Although it is clear that the antigenic switching mechanism
conferred by the vls locus is essential for B. burgdorferi persistence
in the host [65,66], the precise mechanism of vls-dependent
immune evasion remains unknown. Similarly the mechanism of
lmp-1-dependent protection of B. burgdorferi against the host’s
humoral immune response is unknown [67]. VlsE and Lmp-1 are
highly antigenic proteins present on the outer surface of the
spirochete [67–69]. The BBK46 open reading frame appears to
encode a lipoprotein with a predicted signal sequence for outer
surface localization; however, recombinant BBK46 protein
produced in E. coli was not found to be seroreactive when
analyzed by immunoblot using immune sera collected from mice
infected with wild-type B. burgdorferi. Future studies are focused on
elucidation of the role of bbk46 in the pathogenesis of B.
burgdorferi.
In conclusion, we have developed and applied the IVET
technology to B. burgdorferi to identify spirochete genes expressed

[8,10], bbj51 [7,8], bb0551, bbm28 [8], bb0495, and bb0660 [7].
The results of the DMC microarray studies are reported as
genes that are significantly up-regulated in DMC-derived
spirochetes relative to spirochetes grown in vitro; whereas, the
BbIVET screen does not distinguish between genes that are
specifically induced in vivo and genes that are expressed both in
vitro and in vivo. Furthermore, the environmental cues within the
DMCs may not fully reflect those experienced by B. burgdorferi
during an active infection. Finally, the BbIVET system
specifically selects for promoters that are capable of driving
expression of pncA allowing the spirochetes to survive throughout a three week mouse infection. Together, these technical and
biological differences between the DMC microarray and
BbIVET screen likely contributed to the distinct results obtained
from the two methods of gene expression analysis. In addition,
few genes that have been previously established to be RpoSregulated in vitro and/or within DMCs [10,60] were identified
by the BbIVET screen. RpoS-regulated genes bba36, bba57,
bb0265 and bbh01 [10,60] were among the in vivo-expressed Bbive
candidate genes. Similarly, only one putative BosR-regulated
gene, bb0592 [61], was identified in the BbIVET screen.
Although it is unclear why only a small number of know
RpoS-regulated promoters were recovered, the recently identified AT-rich BosR binding site [61] contains the restriction site
for the Tsp509I restriction enzyme used to generate the
BbIVET library. Therefore, it is possible that the BosR binding
sites were subject to cleavage by Tsp509I, perhaps resulting in a
limited number of DNA fragments that contained BosRdependent promoters.
The BbIVET screen was carried out in such a way that both
DNA fragments that are expressed in vitro and in vivo, as well as
those fragments that are specifically induced in vivo, could be
recovered. Therefore, it was not surprising that genes encoding
cell division, DNA replication, energy metabolism, protein
synthesis and transcription functions were identified, all of
which are likely functions essential for spirochete growth under
all condition. These findings were consistent with those
categories of genes not recovered by genome-wide transposon
mutagenesis, suggesting that these genes encode essential
functions [52]. The BbIVET screen identified genes that encode
proteins in functional categories that may contribute to B.
burgdorferi infectivity and pathogenesis including, putative
lipoproteins, motility and chemotaxis proteins, transport proteins and proteins of unknown function. Similarly, transposon
mutagenesis analysis indicated that motility and chemotaxis
genes as well as transport genes are important for B. burgdorferi
survival in the mouse [52].
Linear plasmid 36 is known to be critical for B. burgdorferi
survival in the mouse; however, the genes on lp36 that contribute
to this requirement have not been fully characterized [37]. The
recently published comprehensive STM study suggests that many
of the genes encoded on lp36 participate in B. burgdorferi infectivity
[37,52]. BbIVET identified gene bbk46 on lp36. We found that
bbk46 was expressed both in vitro and in vivo. However, bbk46
expression was dramatically induced in spirochetes isolated from
infected mouse tissues as compared to spirochetes grown in vitro,
suggesting a possible role for this gene in B. burgdorferi infectivity.
Moreover, consistent with lack of identification of bbk46 as an
RpoS-regulated genes in previous studies of the RpoS regulon
[10,62],control of bbk46 expression was found to be RpoSindependent under in vitro growth conditions that typically induce
expression of rpoS regulated genes [4,8,42,60]. These findings
highlight the power and uniqueness of the IVET-based approach
for identification of B. burgdorferi in vivo-expressed genes, which
PLOS Pathogens | www.plospathogens.org
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Table 5. List of primers used in this study.
Sequence (59 – 39)a

Primer number

Designation

1

pncA 59 EcoRI A

cggaattcatgGCACTTATTTTAATAGATATAC

2

pncA 39 XbaI

gctctagaTTATATATTAAGCTTACTTTGGCTG

3

ospC prom 59 EcoRI

cggaattcTTCTTTTTCATTAATTTGTGCCTCC

4

ospC prom 39 EcoRI

cggaattcTTAATTTTAGCATATTTGGCTTTGCTTATGTCG

5

pUC18R BSV2

AGCGGATAACAATTTCACACAG

6

pncA prom 39 seq

ACTGTTAGATACTGGCAAAGTGCC

7

bbk46Fup500

GTTCTTTTATGGAGCAAGCAACTAA

8

bbk46Rup500

CGGAAGCCACAAGAGGCGACAGACACTATCTTAGTACCTCTTCTTAGAATCTG

9

bbk46Fdown500

GGCGAGATCACCAAGGTAGTCGGCAAATAAATAATACTAATCTTAGATAGCTCAGCTTT

10

bbk46Rdown500

CTAGCTTCACTAGTTTCCCTAGA

11

flaBpaadA F

TGTCTGTCGCCTCTTGTG

12

flaBpaadA R

TTATTTGCCGACTACCTTGGTG

13

K4659kpn1fwd

cggggtaccCTTCCAGTGTAGGCTTTAGTTT
TTAtttatcatcatcatctttataatcTGCCTCAACTGCCTTTCTC

14

K4639FLAGrev

15

K4659FLAGfwd

gattataaagatgatgatgataaaTAAAATGCTTCAAAGGAAAATTATGAATGG

16

K4639C-mycSalIrev

acgcgtcgacTTAcagatcttcttcagaaataagtttttgttcATAAGCAGCTTCATATGCTTTATTT

17

K4659PCR3fwd

CGGGGTACCCTTCCAGTGTAG

18

K4639PCR3rev

ACGCGTCGACTTACAGATCTTCTTCAGAAATA

19

Lp3629018F

AGCATTATTTGTACTTCTAGGC

20

Lp3629013R

ACATACTAGACAACAACAAGTC

21

flaBF3

GCATTAACGCTGCTAATCTTAG

22

flaBR3

GCATTAATCTTACCAGAAACTCC

23

recA F

AATAAGGATGAGGATTGGTG

24

recA R

GAACCTCAAGTCTAAGAGATG

25

ospC1 F

ACGGATTCTAATGCGGTTTTACCT

26

ospC1 R

CAATAGCTTTAGCAGCAATTTCATCT

27

flaBp 59 KpnI

gggggtaccTGTCTGTCGCCTCTTGTGGCT

28

flaBp 39 BamHI

gggggatccGATTGATAATCATATATCATTCCT

29

bbk46+S 59 BamHIF

cgggatccATGAATTTAATTGCTAAATTATTTATTTTATCCAC

30

bbk46-S 59 BamHIF

cgggatcc ATGTGTAACCTATATGATAATCTTGCAGAC

31

bbk46 39 XhoIR

ccgctcgag TTAATAAGCAGCTTCATATGCTTTATTTAG

a
Lowercase indicates all non-B. burgdorferi sequence.
doi:10.1371/journal.ppat.1003567.t005

during mammalian infection. This represents the first use of this
system in B. burgdorferi. The power of this system was validated by
identification of a subset of genes that have been demonstrated
previously to be upregulated in vivo. Furthermore, IVET identified
bbk46, a novel, uncharacterized gene located on essential virulence
plasmid lp36. We have presented evidence that bbk46 is highly
upregulated during B. burgdorferi murine infection and is critical for
the spirochete’s ability to persistently infect immunocompetent
mouse tissues. Further analysis of the molecular mechanism of
bbk46-promoted survival, as well as identification and characterization of other putative virulence factors identified by BbIVET,
will contribute to advancing understanding of in vivo persistence
and pathogenicity of B. burgdorferi.

Laboratory Animal Care. Protocols for all animal experiments
were prepared according to the guidelines of the National
Institutes of Health and were reviewed and approved by the
University of Central Florida Institutional Animal Care and Use
Committee (Protocol numbers 09-38 and 12-42).

Bacteria clones and growth conditions
All B. burgdorferi clones used were derived from clone B31 A3.
Clone A3 68-1, which lacks lp25 and lp56 [35] was used for the
pBbIVET library. The B31 A3 wild-type and rpoS::kan B. burgdorferi
clones [70] were used for gene expression experiments. All lowpassage B. burgdorferi mutant and complemented clones generated
herein were derived from infectious clone A3-68DBBE02, which
lacks cp9, lp56 and gene bbe02 on lp25 [51]. B. burgdorferi was
grown in liquid Barbour-Stoenner-Kelly (BSK) II medium
supplemented with gelatin and 6% rabbit serum [71] and plated
in solid BSK medium as previously described [72,73]. All
spirochete cultures were grown at 35uC supplemented with
2.5% CO2. Kanamycin was used at 200 mg/ml, streptomycin

Materials and Methods
Ethics statement
The University of Central Florida is accredited by the
International Association for Assessment and Accreditation of
PLOS Pathogens | www.plospathogens.org
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was used at 50 mg/ml and gentamicin was used at 40 mg/ml, when
appropriate. All cloning steps were carried out using DH5a E. coli,
which were grown in LB broth or on LB agar plates containing
50 mg/ml kanamycin, 300 mg/ml spectinomycin or 10 mg/ml
gentamicin.

tion, spirochetes were reisolated from ear, heart, bladder and joint
tissues in 10 ml BSKII medium containing 20 mg/ml phosphomycin (Sigma), 50 mg/ml rifampicin (Sigma) and 2.5 mg/ml
amphotericin B (Sigma) in 0.2% dimethyl sulfoxide (Sigma). Total
genomic DNA was isolated from each spirochete cultures using the
Wizard genomic DNA purification kit (Promega) and transformed
into chemically competent E. coli DH5a cells and colonies selected
on LB agar containing kanamycin to recover the pBbIVET
plasmids. Twenty four transformants were chosen at random from
each plasmid rescue and colony PCR performed using primers 5
and 6 (Table 5) to amplify the in vivo-expressed DNA fragment.
PCR products were subsequently digested with a cocktail of
restriction enzymes (DraI, SspI and AseI) and visualized on a 1%
agarose gel. Approximately 14,000 E. coli clones were analyzed in
this manner. All unique BbIVET fragments, as determined by the
restriction digest pattern (Figure S1), were analyzed by direct
sequencing of the PCR product using primer 5. Each individual
sequence was identified by blastn analysis and mapped to its
location in the B. burgdorferi B31 genome.

Generation of the pBbIVET plasmid
The promoterless pncA gene was amplified from B. burgdorferi
B31 genomic DNA using primers 1 and 2 (Table 5) and Taq DNA
polymerase (New England Biolabs). The EcoRI/XbaI-digested
pncA fragment was cloned into EcoRI/XbaI-linearized plasmid
pBSV2*TT [23], creating plasmid pBbIVET. The in vivoexpressed ospC promoter with EcoRI ends was amplified from B.
burgdorferi B31 genomic DNA using primers 3 and 4 (Table 5) and
cloned into the EcoRI-cut, Antarctic phosphatase-treated (New
England Biolabs) pBbIVET plasmid in front of the promoterless
pncA gene, resulting in plasmid pBbIVET ospCp. All plasmids were
analyzed and verified by restriction digest and sequence analysis.
The pBbIVET and pBbIVET ospCp plasmids were each transformed by electroporation into A3 68-1 [35] as described [37] and
transformants selected in solid BSK medium containing kanamycin and confirmed by PCR using primers 1 and 2 (Table 5). Total
genomic DNA was prepared from PCR-positive clones and
screened for the presence of the B. burgdorferi plasmid content [70].
The clones that retained the plasmid content of the parent clone
were used in further experiments.

Deletion of bbk46
We used a PCR-based overlap extension strategy to delete the
bbk46 gene. A spectinomycin/streptomycin resistance cassette,
flaBp-aadA [74] with blunt ends, was amplified from genomic DNA
isolated from clone DguaAB [35] using Phusion High-fidelity DNA
polymerase (Thermo Scientific) and primers 11 and 12 (Table 5).
The 500 bp flanking region upstream of the bbk46 ORF was
amplified from the B. burgdorferi B31 clone A3 genomic DNA using
the Phusion High-fidelity DNA polymerase and primers 7 and 8
(Table 5). This introduced a 25 bp sequence at the 39 end of this
fragment that was complementary to the 59 end of the flaBp-aadA
cassette. Similarly, the 500 bp flanking region downstream of the
bbk46 ORF was amplified using the primers 9 and 10 (Table 5),
which introduced a 59 sequence of 30 bp that was complementary
to the 39 end of the resistance cassette. The PCR products from
the above 3 reactions were mixed in equal volumes and used as a
template for a fourth amplification reaction using Phusion Highfidelity DNA polymerase and primers 7 and 10 (Table 5) in order
to generate a product containing the resistance cassette flanked by
the 500 bp sequences upstream and downstream of the bbk46
ORF. This product was ligated with linear pCR-Blunt using a
Zero Blunt PCR cloning Kit (Life technologies), yielding the allelic
exchange plasmid pCR-Blunt-Dbbk46-flaBp-aadA. B. burgdorferi A368DBBE02 was transformed with 20 mg of pCR-Blunt-Dbbk46flaBp-aadA purified from E. coli as previously described [37].
Streptomycin-resistant colonies were confirmed to be true
transformants by PCR using primer pairs 7 and 10 and 11 and
12 (Table 5). Positive Dbbk46-flaBp-aadA clones were screened with
a panel of primers [70] for the presence of all of the B. burgdorferi
plasmids of the parent A3-68DBBE02 clone [51], and a single
clone was selected for further experiments.

Generation of the BbIVET library
Total genomic DNA was isolated from a 250 ml culture of B.
burgdorferi B31 clone A3 grown to a density 16108 spirochetes/ml
using the Qiagen genomic DNA buffer set and Genomic-tip 500/
G, according to the manufacturer’s protocol (Qiagen). A3 genomic
DNA was partially digested with Tsp509I (New England Biolabs).
The partial digests were electrophoretically separated on a 0.8%
agarose gel and the 300 to 500 bp range of DNA fragments
extracted and ligated in a 1:1 molar ratio with EcoRI-digested and
Antarctic phosphatase-treated pBbIVET. Library ligations were
electroporated into E. coli Top10 cells (Life Technologies) and
transformants selected on LB agar containing 50 mg/ml kanamycin, resulting in approximately 30,000 independent clones.
Plasmid DNA was isolated from these cells and 20 mg aliquots of
the plasmid library were transformed by electroporation into B.
burgdorferi A3 68-1, as previously described [73]. One fifth of each
transformation was plated on solid BSK medium containing
kanamycin. B. burgdorferi pBbIVET colonies were verified to
contain B. burgdorferi DNA fragments by PCR using primers 5 and
6 (Table 5) and the number of transformants recovered
quantitated. The approximately 15,000 B. burgdorferi clones
recovered over 40 transformations were stored in aliquots of pools
of approximately 100 BbIVET clones each in 25% glycerol at
280uC.

Complementation of the Dbbk46 mutant

Selection of B. burgdorferi clones having in vivoexpressed DNA fragments

A PCR-based overlap extension strategy was used to create a
DNA fragment encompassing the bbk46 gene and putative
upstream promoter sequence with the introduction of a FLAG
epitope tag immediately upstream of the putative premature stop
codon and a cMyc epitope tag immediately upstream of the
downstream stop codon. This was done by using Phusion Highfidelity DNA polymerase (New England Biolabs) and the primers
pairs 13 and 14, 15 and 16, and 17 and 18 (Table 5). A KpnI
restriction site was introduced at the 59 end of this fragment and a
SalI site at the 39 end. The KpnI+SalI-digested PCR product was
ligated into KpnI+ SalI-digested B. burgdorferi shuttle vector

Each BbIVET pool (,100 clones) was grown in 10 ml of fresh
BSKII medium to a density of 16108 spirochetes/ml. In groups of
approximately 20 animals, 144 6–8 week old C3H/HeN female
mice were each inoculated (80% intraperitoneal and 20%
subcutaneous) with a dose 16106 spirochetes of a unique pool of
,100 BbIVET clones, under the assumption that each clone was
present at dose 16104 spirochetes. A fraction of each inoculum
was plated on solid BSK medium and colonies screened for the
presence of virulence plasmid lp28-1. Three weeks post inoculaPLOS Pathogens | www.plospathogens.org
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pBSV2G [75] and cloned in E. coli. The pBSV2G bbk46p-bbk46FLAG-cMyc plasmid structure and sequence were confirmed by
restriction digest and DNA sequence analysis. In addition, a
400 bp DNA fragment encompassing the flaB promoter with KpnI
and BamHI ends was amplified from B31 A3 genomic DNA using
primers 27 and 28 (Table 5). The KpnI+BamHI-digested PCR
product was ligated into KpnI+ BamHI-digested B. burgdorferi
shuttle vector pBSV2G [75]. The bbk46-FLAG-cMyc gene without
the putative bk46 promoter sequence and with BamHI and SalI
ends was amplified from pBSV2G bbk46p-bbk46-FLAG-cMyc
plasmid DNA using Phusion High-fidelity DNA polymerase
(New England Biolabs) and primers 29 and 18 (Table 5). The
BamHI+SalI-digested PCR product was ligated into BamHI+SalIdigested pBSV2GflaBp and cloned in E. coli. The pBSV2G flaBpbbk46-FLAG-cMyc plasmid structure and sequence were confirmed
by restriction digest and DNA sequence analysis. The Dbbk46
mutant was transformed with 20 mg of pBSV2G bbk46p-bbk46FLAG-cMyc, pBSV2G flaBp-bbk46-FLAG-cMyc or pBSV2G alone
isolated from E. coli and positive transformants selected as
previously described [37,76]. The clones that retained the B.
burgdorferi plasmid content of the parent clone were selected for use
in further experiments.

E. coli, B. burgdorferi B31 A3 and E. coli expressing B. burgdorferi bmpA
[37] prepared as described above. The membrane was stripped as
described above and reprobed with anti-GST primary monoclonal
antibody (EMD Millipore) diluted 1:1000 in TBST and goat antimouse IgG+IgM-HRP (EMD Millipore) and visualized as
described above.

In vitro growth analysis
Wild-type (A3-68DBBE02), Dbbk46/vector and Dbbk46/
bbk46+ spirochetes were inoculated in triplicate at a density of
16105 spirochetes/ml in 5 ml of BSK II medium. Spirochete
densities were determined every 24 hours under dark field
microscopy using a Petroff-Hausser chamber over the course of
96 hours.

RNA isolation from in vitro grown spirochetes
To obtain in vitro grown log phase spirochetes, wild-type (B31
A3) spirochetes were grown in triplicate in 5 ml of BSKII medium
pH 7.5 at 35uC to a density of 36107 spirochetes/ml. To obtain
stationary phase, temperature-shifted spirochetes, wild-type (B31
A3) spirochetes were grown in triplicate in 5 ml of BSKII medium
pH 7.5 at 35uC to a density of 36107 spirochetes/ml, transferred
to 25uC for 48 hours and then returned to 35uC for an additional
24–36 hours to a density of 26108 spirochetes/ml. A total of
16107 spirochetes were harvested from each culture and total
RNA was isolated using TRIzol reagent (Life Technologies)
according to the manufacturer’s instructions. RNA was resuspended in 100 ml DEPC-treated dH2O. RNA was treated with
TURBO DNA-free (Life Technologies) to remove any contaminating genomic DNA. 1 ml of Riboguard (40 U/ml) RNAse
inhibitor (Epicentre) was added to all samples and RNA stored
at 280uC.

Immunoblot analysis of BBK46-FLAG-cMyc
Production of the BBK46-FLAG-cMyc protein was examined
in both E. coli and B. burgdorferi carrying pBSV2G bbk46p-bbk46FLAG-cMyc or pBSV2G flaBp-bbk46-FLAG-cMyc. Total E. coli
protein lysates were prepared from 26109 cells harvested following
overnight growth in LB medium at 37uC with aeration. E. coli cells
were resuspended and lysed in 200 ml B-PER protein extraction
reagent (Pierce), followed by the addition of 200 ml 26 Laemmli
sample buffer plus 2-mercaptoethanol (Bio-rad). Total B. burgdorferi
protein lysates were prepared from 26109 spirochetes harvested at
mid-log phase. The spirochetes were washed twice in 1 ml cold
HN buffer (50 mM Hepes, 50 mM NaCl, pH 7.4) and lysed in
200 ml B-PER protein extraction reagent (Thermo Scientific),
followed by the addition of 200 ml 26 Laemmli sample buffer plus
2-mercaptoethanol (Bio-rad). 30 ml of each protein lysate
(,1.56108 cells) were separated by SDS-PAGE and transferred
to a nitrocellulose membrane. 300 ng of PncA-FLAG [23] and
GST-BmpA-cMyc [77] proteins served as positive controls.
Immunoblot analysis was performed using anti-FLAG monoclonal
primary antibody (Genscript) diluted 1:500 in Tris-buffered saline,
pH 7.4 and 0.5% Tween20 (TBST) and goat anti-mouse
IgG+IgM-HRP secondary antibody (EMD Millipore) diluted
1:10,000 in TBST and the signal detected using SuperSignal
West Pico chemluminescent substrate kit (Thermo Scientific). The
membrane was then stripped using 0.2 M NaOH, reblocked using
5% skim milk in TBST and probed with anti-cMyc primary
antibody (Genscript) diluted 1:500 in TBST and goat anti-mouse
IgG+IgM-HRP (EMD Millipore) and visualized as described
above.

RNA isolation from infected mouse tissue
B. burgdorferi-infected mouse bladders (see mouse infection
experiments below) were manually macerated on ice using sterile
scalpels and transferred to a 2 ml sterile tube containing lysing
Matrix D (MP Biomedicals). 1 ml of RNA pro solution (FastRNA
Pro Green kit, MP Biomedicals) was added to each sample on ice.
Tissues were homogenized using a PowerGen High-Throughput
Homogenizer (Fisher Scientific) following six cycles of beating for
45 sec and 2 minute incubations on ice. Samples were centrifuged at 13,000 rpm for 5 minutes at 4uC. The upper aqueous
phase was transferred to new tubes and incubated for 5 minutes
at room temperature. 500 ml of 1-bromo-3-chloropropane (Sigma
Aldrich) and 45 ml of 5 M sodium acetate were added to each
sample and samples were incubated for an additional 5 minutes
at room temperature. Samples were centrifuged at 13,000 rpm
for 5 minutes at 4uC. The upper aqueous phase was transferred
to new tubes and RNA precipitated with the addition of 500 ml of
absolute ethanol and 1 ml GlycoBlue (Life technologies). RNA
was pelleted by centrifugation at 13,000 rpm for 10 minutes at
4uC. RNA was washed with 70% ethanol in DEPC-treated dH20
and resuspended in 100 ml DEPC-treated dH20. RNA was
treated with TURBO DNA-free (Life Technologies) to remove
any contaminating genomic DNA. 1 ml Riboguard (40 U/ml)
RNAse inhibitor (Epicentre) was added to all samples and RNA
stored at 280uC.

Cloning, purification and seroreactivity analysis of rGSTBBK46
An in-frame glutathinone S-transferase (GST)-BBK46 fusion
protein lacking the putative BBK46 signal sequence was generated
using primers 30 and 31 (Table 5) and purified, as previously
described [77]. Approximately 1 mg of GST-BBK46 was separated
by SDS-PAGE, transferred to a nitrocellulose membrane and
analyzed by immunoblot for seroreactivity using immune serum
collected 3 weeks post inoculation from mice infected with wildtype B. burgdorferi as previously described [77]. Controls included
1 mg of GST alone and total protein lysates generated from BL21
PLOS Pathogens | www.plospathogens.org
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cDNA was synthesized from 1.0 mg of each RNA sample using
the iScript cDNA synthesis kit (Bio-Rad) with random primers
according to the manufacturer’s instructions. Parallel cDNA
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reactions were carried out in the absence of reverse transcriptase.
Real-time quantitative PCR (qPCR) reactions were prepared using
1 mg of each cDNA and iQ SYBR Green Supermix (Bio-Rad).
Using an Applied Biosystems 7500 instrument, samples were
assayed for the flaB, recA, ospC and bbk46 transcripts using primers
pairs 21 and 22, 23 and 24, 25 and 26, and 19 and 20, respectively
(Table 5). Standard curves were generated for each gene target
using 100 ng, 10 ng, 1.0 ng, 0.1 ng, and 0.01 ng of B31 A3 B.
burgdorferi genomic DNA and the amount of each gene transcript
calculated. The recA transcript was used as the endogenous
reference to which the transcripts of the other genes were
normalized. The bbk46 primers were confirmed to be specific for
their gene target. Three biological replicate samples were analyzed
in triplicate and normalized to recA mRNA. The data were
reported as the average gene transcript/recA transcript for each
sample. The amplification of samples lacking reverse transcriptase
was similar to that of the no-template control.

infection was assessed three weeks post inoculation by serology
using total B. burgdorferi lysate, as previously described [37] and
300 ng recombinant GST-OspC [77], as previously described
[79]. Spirochetes were reisolated from the inoculation site, ear,
bladder and joint tissues, as previously described [37].
Groups of five immunodeficient C3SnSmn.CB17-Prkdc,scid./J
(Jackson labs stock 001131) were needle-inoculated with B. burgdorferi
clones wild-type (A368DBBE02 [51]), Dbbk46/vector or Dbbk46/
bbk46+ at a dose of 16104 spirochetes. 80% of the inoculum was
delivered intraperitoneal and 20% of the inoculum was delivered
subcutaneous. The inoculum cultures were analyzed as described
above. Mouse infection was assessed three weeks post inoculation by
reisolation of spirochetes from ear, bladder and joint tissues [37].

Supporting Information
Figure S1 Representative restriction digest analysis of
individual pBbIVET plasmids rescued in E. coli. Colony
PCR to amplify the in vivo-expressed DNA fragment was performed
on a random subset of twenty four E. coli transformants carrying the
rescued pBbIVET plasmids from infected mouse tissues. The PCR
products were digested with a cocktail of the restriction enzymes
DraI, SspI and AseI and separated on a 1% agarose gel. Numbers
across the top of each image identify each non-identical restriction
digestion pattern detected for the amplified pBbIVET DNA
fragments. Representative data from two mouse tissues (A) and (B)
are shown. Migration of the DNA ladders is shown in base pairs on
both sides of each image. NTC, PCR no template control.
(TIF)

Mouse infection experiments
Unless otherwise noted, groups of 6–8 week old C3H/HeN
female mice (Harlan) were used for all experiments.
ID50 analysis of mammalian-adapted spirochetes. A
single C3H/HeN SCID mouse (Harlan) was inoculated with
26106 B. burgdorferi B31 A3. Two weeks post infection the infected
blood was harvested and used to inoculate groups of six wild-type
C3H/HeN (Harlan) mice with 100 ml of undiluted infected blood
or 100 ml of infected blood diluted 1:10 or 1:100 in BSK-H
medium. The number of live spirochetes in the infected blood and
therefore the actual spirochete dose in the inoculum was
determined by plating the blood in solid BSK medium and
quantitating the number of colony forming units (Table 1). In
addition, groups of six wild-type C3H/HeN mice (Harlan) were
inoculated with 56104, 56103, 56102, 56101 or 56100, in vitro
grown spirochetes at mid-log phase. The in vitro grown spirochetes
were confirmed to harbor all plasmids required for infectivity [70].
Functional validation of the BbIVET system. Groups of 6
mice were needle inoculated as described [76] with 16104
spirochetes of clone A3 68-1 carrying pBbIVET or pBbIVETospCp. Mouse infection was assessed 3 weeks post inoculation by
reisolation of spirochetes from ear, bladder and joint tissues as
previously described [70,78].
Gene expression studies. Three mice were needle-inoculated intradermally under the skin of the upper back with B.
burgdorferi clone B31 A3 at a dose of 16105 spirochetes. Three
weeks post inoculation mouse infection was determined by
serology [70,78] and bladders harvested for RNA isolation.
bbk46 mutant infectivity studies. Groups of five mice were
needle-inoculated, intradermally under the skin of the upper back,
with B. burgdorferi clones wild-type (A3-68DBBE02 [51]), Dbbk46/
vector or Dbbk46/bbk46+ at a dose of 16104 spirochetes. The
number of spirochetes inoculated into mice was determined using
a Petroff-Hausser counting chamber and verified by colonyforming unit (cfu) counts in solid BSK medium. Twelve colonies
per inoculum were verified by PCR for the presence of the
virulence plasmids lp25, lp28-1 and lp36 in at least 90% of the
individuals in the population. Further, total plasmid content of
each inoculum was confirmed to be as expected [37,70,76]. Mouse

Figure S2 The BBK46 protein is non-immunogenic in
mice. Recombinant GST-BBK46 and GST alone produced in
and purified from E. coli, along with total protein lysate from E. coli
and B. burgdorferi (Bb lysate) and E. coli producing the B. burgdorferi
antigen BmpA (+) were separated by SDS-PAGE and transferred
to a nitrocellulose membrane. Immunoblot analysis was performed
using immune serum collected from mice infected with wild-type
B. burgdorferi and anti-GST monoclonal antibodies (a GST). The
positions of markers to the left of the panel depict protein standard
molecular masses in kilodaltons.
(TIF)
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